Lonza | LONN - Current Liabilities


Lonza reported CHF3.57B in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Akzo Nobel EUR 4.31B 77M Jun/2026
Alcon AG USD 3.17B 163M Jun/2026
Almirall EUR 323.65M 26.99M Jun/2026
AstraZeneca USD 31.55B 1.02B Jun/2026
BASF EUR 20.91B 1.26B Jun/2026
Bayer EUR 32.27B 1.19B Jun/2026
Beiersdorf EUR 3.51B 261M Dec/2025
Covestro EUR 3.87B 299M Dec/2025
Demant DKK 12.42B 5B Jun/2026
Fresenius EUR 9.07B 468M Jun/2026
Fresenius Medical Care EUR 7.18B 448.03M Jun/2026
Geberit CHF 854.7M 192.6M Dec/2024
Genmab DKK 1.14B 38M Jun/2026
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 21.53B 895M Jun/2026
GN Store Nord DKK 4.81B 2.5B Mar/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Johnson Matthey GBP 2.53B 211M Jun/2026
Merck EUR 8.12B 1.22B Jun/2026
Novartis USD 31.75B 374M Jun/2026
Philips EUR 7.42B 8M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Sika AG CHF 3.53B 730M Dec/2025
Smith & Nephew USD 2.05B 510M Jun/2026
Solvay EUR 1.78B 6M Jun/2026
UCB EUR 4.4B 470M Dec/2025